USPTO serial 87103711
LUMIRADX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 27, 2020
- Examiner
- EVANKO, PATRICIA MALESARDI
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with LUMIRADX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
London, GB
London, GB
Roche Diagnostics International AG
Rotkreuz, CH
Other trademarks owned by Roche Diagnostics International AG
London, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mona Gupta
Mona Gupta Roche Diagnostics Operations, Inc.9115 Hague RoadIndianapolis, IN 46250United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Diagnostic, examination and monitoring equipment for medical purposes, namely, apparatus for the detection of infectious diseases [ , cardiovascular diseases and conditions, diabetes, cancer, women's health including pregnancy, sexually transmitted diseases, hematology and drugs of abuse ] ; medical diagnostic apparatus for the detection of chronic diseases, infectious diseases [ , cardiovascular diseases and conditions, diabetes, cancer, women's health including pregnancy, sexually transmitted diseases, hematology and drugs of abuse ] ; medical diagnostic instruments for detecting chronic diseases, infectious diseases [ , cardiovascular diseases and conditions, diabetes, cancer, women's health including pregnancy, sexually transmitted diseases, hematology and drugs of abuse ] ; diagnostic instruments for medical use for the testing and analysis of assays; [ electronic apparatus for medical purposes for the monitoring of glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, vital signs and detection of chronic diseases, infectious diseases, cardiovascular diseases and conditions, diabetes, cancer, women's health including pregnancy, sexually transmitted diseases, hematology and drugs of abuse; ] analytical instruments for medical use, namely device for [ monitoring glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, vital signs and ] detection of chronic diseases, infectious diseases [ , cardiovascular diseases and conditions, diabetes, cancer, women's health including pregnancy, sexually transmitted diseases, hematology and drugs of abuse ] ; apparatus for carrying-out diagnostic tests for medical purposes, namely [ measurement and ] detection of [ glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, vital signs and detection of ] chronic diseases, infectious diseases [ , cardiovascular diseases and conditions, diabetes, cancer, women's health including pregnancy, sexually transmitted diseases, hematology and drugs of abuse ] ; apparatus for use in medical analysis, namely, medical diagnostic instruments for the analysis of [ glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, vital signs and ] detection of chronic diseases, infectious diseases [ , cardiovascular diseases and conditions, diabetes, cancer, women's health including pregnancy, sexually transmitted diseases, hematology and drugs of abuse; diagnostic measuring apparatus for medical use, namely device for monitoring glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, and vital signs, blood counts and blood analysis ] ; apparatus for blood analysis for medical purposes; [ medical instruments for drug abuse testing; medical apparatus for detecting drugs of abuse; ] medical apparatus for detecting and measuring the level of substances in bodily fluids; and parts and fittings for all the aforesaid goods, included in the class | ACTIVE | — |
| 044 | [ Healthcare services; medical diagnostic testing and reporting services; ] providing medical information and advisory services; consulting services in the field of health; medical consulting regarding medical diagnostic apparatus and instruments; [ advice relating to the medical needs of elderly people; ] providing medical advisory services relating to medical instruments; [ providing medical advisory services relating to medical services; medical reporting services, namely, compilation of medical reports; medical analysis services, namely, providing medical record analysis and assessment services designed to provide patients and healthcare professionals with customized diagnostic information, patient diagnoses, medical treatment plans and healthcare management plans; medical health assessment services; medical screening; medical services for the diagnosis of conditions of the human body; medical testing for diagnostic purposes; surgical diagnostic services; health and medical services delivered via online interactive database enabling medical device users to exchange information with healthcare providers; advice, consultancy and information on the aforesaid, included in the class; ] online health and medical services, namely, providing an interactive database for exchanging health and medical information between a medical device user and healthcare providers, delivered via a global computer network | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LUMIRADX INTERNATIONAL LTD
- Other trademarks owned by LUMIRADX INTERNATIONAL LTD
- Other trademarks owned by Roche Diagnostics International AG
- Other trademarks owned by LUMIRADX INTERNATIONAL LTD
- Other trademarks in Class 010
- Other trademarks in Class 044
- Similar marks named LUMIRADX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 19, 2026 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| May 19, 2026 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Apr 24, 2026 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Apr 24, 2026 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Apr 24, 2026 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Apr 24, 2026 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Apr 24, 2026 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Mar 30, 2026 | PR23 | POST REGISTRATION ACTION MAILED - SEC. 8 & 15 | — |
| Mar 30, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jan 6, 2026 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Oct 27, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Sep 13, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 13, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 13, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 13, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 11, 2024 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Aug 16, 2024 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Apr 7, 2021 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Oct 27, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 23, 2020 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Sep 11, 2020 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Sep 11, 2020 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Mar 18, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 17, 2020 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Mar 17, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 9, 2020 | EXT5 | SOU EXTENSION 5 FILED | — |
| Mar 9, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 13, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 11, 2019 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Sep 11, 2019 | EXT4 | SOU EXTENSION 4 FILED | — |
| Sep 11, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 13, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 11, 2019 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Mar 11, 2019 | EXT3 | SOU EXTENSION 3 FILED | — |
| Mar 11, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 11, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 9, 2018 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Aug 9, 2018 | EXT2 | SOU EXTENSION 2 FILED | — |
| Aug 9, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 6, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 2, 2018 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Mar 2, 2018 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 2, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 12, 2017 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 18, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 18, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 28, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 14, 2017 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Jun 9, 2017 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Jun 1, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 31, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 30, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 30, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 31, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 31, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 31, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 30, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 29, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 29, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 8, 2017 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Oct 30, 2016 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 30, 2016 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 12, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 12, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 12, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 6, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 20, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 18, 2016 | NWAP | NEW APPLICATION ENTERED | — |